The American Society of Hematology (ASH) released a statement from President Charles S. Abrams, MD, congratulating Congress on the passage of a short-term resolution to fund the National Institutes of Health (NIH) and other federal programs through December 9. ASH also applauds the inclusion of emergency supplemental funding for public health emergencies such as Zika. However, the Society remains concerned about the ongoing impact that limited funding extensions have on medical advancements that are dependent upon sustained and predictable support.
Last year, Congress showed a strong bipartisan commitment to support biomedical research by providing a $2 billion increase for NIH in fiscal year (FY) 2016. Yet, if the nation is to continue to accelerate the development of life-changing cures, pioneering treatments, and innovative prevention strategies, it is essential for Congress to maintain this commitment. ASH urges Congress to make it a priority when it reconvenes in November to pass full and final spending legislation that includes $34.1 billion for NIH for FY 2017.
ASH said it remains committed to working with lawmakers to pass a full FY2017 that ensures that lifesaving biomedical research continues, while promoting public health and safety.